Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.515
-0.015 (-0.98%)
Mar 9, 2026, 1:16 PM EDT - Market open
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $21.65 million as of March 9, 2026. Its market cap has decreased by -21.28% in one year.
Market Cap
21.65M
Enterprise Value
1.72M
1-Year Change
-21.28%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $21.65M, a decrease of -77.91%. That is a compound annual growth rate of -11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 21.90M | -20.65% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 23.29M |
| Skye Bioscience | 23.09M |
| Marker Therapeutics | 23.01M |
| IO Biotech | 21.62M |
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |